miR-26a inhibits atherosclerosis progression by targeting TRPC3

BACKGROUND: Atherosclerosis, a chronic multi-factorial vascular disease, has become a predominant cause of a variety of cardiovascular disorders. miR-26a was previously reported to be involved in atherosclerosis progression. However, the underlying mechanism of miR-26a in atherosclerosis remains to...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Min, Xu, Daqian, Wang, Lirui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775568/
https://www.ncbi.nlm.nih.gov/pubmed/29387339
http://dx.doi.org/10.1186/s13578-018-0203-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775568/
https://www.ncbi.nlm.nih.gov/pubmed/29387339
http://dx.doi.org/10.1186/s13578-018-0203-9

Ejemplares similares